Standout Papers

Detection of Circulating Tumor Necrosis Factor after Endotoxin Administration 1988 2026 2000 2013 1.3k
  1. Detection of Circulating Tumor Necrosis Factor after Endotoxin Administration (1988)
    H. R. Michie, Kirk R. Manogue et al. New England Journal of Medicine
  2. Gemcitabine and Docetaxel in Patients With Unresectable Leiomyosarcoma: Results of a Phase II Trial (2002)
    Martee L. Hensley, Robert G. Maki et al. Journal of Clinical Oncology
  3. Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma (2019)
    Yanxia Zhao, Alexander Melamed et al. Proceedings of the National Academy of Sciences

Immediate Impact

9 by Nobel laureates 19 from Science/Nature 79 standout
Sub-graph 1 of 17

Citing Papers

The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
2021 Standout
19 intermediate papers

Works of David R. Spriggs being referenced

Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma
2019 Standout
Phase II Study of CT-2103 in Patients With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
2004
and 19 more

Author Peers

Author Last Decade Papers Cites
David R. Spriggs 4177 4808 2045 2929 229 12.8k
Kunle Odunsi 4923 7032 1661 8005 361 15.1k
Michael S. Gordon 5722 8052 589 3382 321 15.0k
Vincent T. DeVita 1866 4898 837 885 183 13.6k
Alice P. Chen 4600 4271 465 1173 295 10.8k
John F. Smyth 3681 2863 1131 1193 198 8.1k
David W. Hedley 6851 6529 676 1194 318 17.0k
Jacqueline Whang‐Peng 5578 4959 335 1545 314 14.8k
Phyllis A. Gimotty 8302 10374 752 5571 238 19.7k
Peter J.K. Kuppen 3529 5213 330 3365 310 11.6k
Lucio Miele 10617 5254 431 2880 274 17.9k

All Works

Loading papers...

Rankless by CCL
2026